These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18223465)

  • 21. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
    Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
    J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of norvancomycin fluorescence polarization immunoassay for therapeutic drug monitoring.
    Wu XJ; Zhang J; Yu JC; Cao GY; Shi YG; Zhang YY; Wang MG
    J Antibiot (Tokyo); 2012 Jan; 65(1):35-9. PubMed ID: 22045420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of weight with assay error on gentamicin pharmacokinetics using the Bayesian and nonlinear least square regression analysis in appendicitis patients.
    Burm JP
    Biopharm Drug Dispos; 2005 Jul; 26(5):189-94. PubMed ID: 15906419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.
    del Mar Fernández de Gatta Garcia M; Revilla N; Calvo MV; Domínguez-Gil A; Sánchez Navarro A
    Intensive Care Med; 2007 Feb; 33(2):279-85. PubMed ID: 17165021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
    Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
    Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF; Petros WP; Soucie MP; Copeland KR
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of collection tube on measured gentamicin and vancomycin concentrations.
    Rayner CR; Ioannides-Demos LL; Spicer WJ; D'Agostino J; Bailey M; Krum H
    Am J Health Syst Pharm; 1999 Jul; 56(14):1457-8. PubMed ID: 10428456
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term accuracy of fluorescence polarization immunoassays for gentamicin, tobramycin, netilmicin and vancomycin.
    Joos B; Lüthy R; Blaser J
    J Antimicrob Chemother; 1989 Nov; 24(5):797-803. PubMed ID: 2599999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
    Blunden M; Zeitlin D; Ashman N; Fan SL
    Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two methods to obtain a desired first isepamicin peak in intensive care patients.
    Fauvelle F; Coulaud JM; Lecointre K; Tardy D; Poussel JF; Trape G
    Fundam Clin Pharmacol; 2001 Apr; 15(2):151-6. PubMed ID: 11468025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
    Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
    Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
    DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
    Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gentamicin and vancomycin removal by continuous venovenous hemofiltration.
    Thomson AH; Grant AC; Rodger RS; Hughes RL
    DICP; 1991 Feb; 25(2):127-9. PubMed ID: 2058183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a common spreadsheet program to demonstrate the ability of Bayesian forecasting to estimate the pharmacokinetic parameters of antibiotics.
    Brocks DR; Wang M
    J Pharm Pharmacol; 2023 Oct; 75(10):1378-1387. PubMed ID: 37478874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The characteristics and impact indicator of vancomycin pharmacokinetics in cancer patients complicated with severe pneumonia.
    Zhang X; Wang D
    J Infect Chemother; 2020 May; 26(5):492-497. PubMed ID: 31983615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of high-performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure.
    Najjar TA; al-Dhuwailie AA; Tekle A
    J Chromatogr B Biomed Appl; 1995 Oct; 672(2):295-9. PubMed ID: 8581137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of biochemical parameters of liver function on vancomycin pharmacokinetics.
    Martí R; Rosell M; Pou L; García L; Pascual C
    Pharmacol Toxicol; 1996 Aug; 79(2):55-9. PubMed ID: 8878246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a pediatric population pharmacokinetic model for vancomycin.
    Hahn A; Frenck RW; Zou Y; Vinks AA
    Ther Drug Monit; 2015 Jun; 37(3):413-6. PubMed ID: 25423413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.